The University of Chicago Header Logo

Connection

Elliot Gershon to Psychotic Disorders

Back to Details
This is a "connection" page, showing publications Elliot Gershon has written about Psychotic Disorders.
Elliot Gershon
Connection Strength
9.322
Psychotic Disorders
  1. An opportunity for primary prevention research in psychotic disorders. Schizophr Res. 2022 05; 243:433-439.
    View in: PubMed
    Score: 0.676
  2. NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis. Transl Psychiatry. 2019 09 17; 9(1):230.
    View in: PubMed
    Score: 0.595
  3. Gyrification across psychotic disorders: A bipolar-schizophrenia network of intermediate phenotypes study. Schizophr Res. 2024 Sep; 271:169-178.
    View in: PubMed
    Score: 0.208
  4. Evidence from comprehensive independent validation studies for smooth pursuit dysfunction as a sensorimotor biomarker for psychosis. Sci Rep. 2024 06 15; 14(1):13859.
    View in: PubMed
    Score: 0.207
  5. Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis Biotypes. Adv Neurobiol. 2024; 40:685-723.
    View in: PubMed
    Score: 0.200
  6. Clinical characterization and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT)-1. Schizophr Res. 2023 10; 260:143-151.
    View in: PubMed
    Score: 0.195
  7. Peripheral inflammatory subgroup differences in anterior Default Mode network and multiplex functional network topology are associated with cognition in psychosis. Brain Behav Immun. 2023 11; 114:3-15.
    View in: PubMed
    Score: 0.194
  8. Characterization of childhood trauma, hippocampal mediation and Cannabis use in a large dataset of psychosis and non-psychosis individuals. Schizophr Res. 2023 05; 255:102-109.
    View in: PubMed
    Score: 0.190
  9. Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disorders. Schizophr Res. 2023 05; 255:69-78.
    View in: PubMed
    Score: 0.190
  10. Reduced task-evoked pupillary response in preparation for an executive cognitive control response among individuals across the psychosis spectrum. Schizophr Res. 2022 10; 248:79-88.
    View in: PubMed
    Score: 0.182
  11. Regional and Sex-Specific Alterations in the Visual Cortex of Individuals With Psychosis Spectrum Disorders. Biol Psychiatry. 2022 09 01; 92(5):396-406.
    View in: PubMed
    Score: 0.178
  12. Using psychosis biotypes and the Framingham model for parsing psychosis biology. Schizophr Res. 2022 04; 242:132-134.
    View in: PubMed
    Score: 0.175
  13. Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium. Schizophr Bull. 2022 01 21; 48(1):56-68.
    View in: PubMed
    Score: 0.175
  14. Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP Study. Schizophr Res. 2022 05; 243:489-499.
    View in: PubMed
    Score: 0.173
  15. Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2022 03 08; 113:110464.
    View in: PubMed
    Score: 0.172
  16. Neural Processing of Repeated Emotional Scenes in Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder. Schizophr Bull. 2021 08 21; 47(5):1473-1481.
    View in: PubMed
    Score: 0.170
  17. Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features. Am J Psychiatry. 2021 10 01; 178(10):952-964.
    View in: PubMed
    Score: 0.170
  18. Biomarker Profiles in Psychosis Risk Groups Within Unaffected Relatives Based on Familiality and Age. Schizophr Bull. 2021 07 08; 47(4):1058-1067.
    View in: PubMed
    Score: 0.168
  19. Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders. Neuropsychopharmacology. 2021 09; 46(10):1802-1810.
    View in: PubMed
    Score: 0.168
  20. Reduced white matter microstructure in bipolar disorder with and without psychosis. Bipolar Disord. 2021 12; 23(8):801-809.
    View in: PubMed
    Score: 0.164
  21. Antisaccade error rates and gap effects in psychosis syndromes from bipolar-schizophrenia network for intermediate phenotypes 2 (B-SNIP2). Psychol Med. 2022 10; 52(13):2692-2701.
    View in: PubMed
    Score: 0.164
  22. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis. Mol Psychiatry. 2021 07; 26(7):3430-3443.
    View in: PubMed
    Score: 0.160
  23. Biotyping in psychosis: using multiple computational approaches with one data set. Neuropsychopharmacology. 2021 01; 46(1):143-155.
    View in: PubMed
    Score: 0.160
  24. Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives. Schizophr Res. 2020 09; 223:236-241.
    View in: PubMed
    Score: 0.159
  25. Resting state auditory-language cortex connectivity is associated with hallucinations in clinical and biological subtypes of psychotic disorders. Neuroimage Clin. 2020; 27:102358.
    View in: PubMed
    Score: 0.158
  26. Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder. Schizophr Res. 2020 09; 223:148-157.
    View in: PubMed
    Score: 0.157
  27. Testing Psychosis Phenotypes From Bipolar-Schizophrenia Network for Intermediate Phenotypes for Clinical Application: Biotype Characteristics and Targets. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 08; 5(8):808-818.
    View in: PubMed
    Score: 0.155
  28. Retinal layer abnormalities and their association with clinical and brain measures in psychotic disorders: A preliminary study. Psychiatry Res Neuroimaging. 2020 05 30; 299:111061.
    View in: PubMed
    Score: 0.153
  29. NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP). Schizophr Res. 2020 04; 218:318-320.
    View in: PubMed
    Score: 0.152
  30. Brain gray matter network organization in psychotic disorders. Neuropsychopharmacology. 2020 03; 45(4):666-674.
    View in: PubMed
    Score: 0.151
  31. Smooth pursuit eye movement deficits as a biomarker for psychotic features in bipolar disorder-Findings from the PARDIP study. Bipolar Disord. 2020 09; 22(6):602-611.
    View in: PubMed
    Score: 0.151
  32. Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches. Schizophr Res. 2020 01; 215:430-438.
    View in: PubMed
    Score: 0.148
  33. Association of Choroid Plexus Enlargement With Cognitive, Inflammatory, and Structural Phenotypes Across the Psychosis Spectrum. Am J Psychiatry. 2019 07 01; 176(7):564-572.
    View in: PubMed
    Score: 0.146
  34. Auditory steady-state EEG response across the schizo-bipolar spectrum. Schizophr Res. 2019 07; 209:218-226.
    View in: PubMed
    Score: 0.145
  35. Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1. Schizophr Bull. 2019 01 01; 45(1):222-232.
    View in: PubMed
    Score: 0.142
  36. VEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study. Transl Psychiatry. 2018 10 11; 8(1):215.
    View in: PubMed
    Score: 0.139
  37. Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders. Hum Brain Mapp. 2019 01; 40(1):163-174.
    View in: PubMed
    Score: 0.139
  38. Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Transl Psychiatry. 2018 04 12; 8(1):78.
    View in: PubMed
    Score: 0.135
  39. Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study. Transl Psychiatry. 2017 10 24; 7(10):e1249.
    View in: PubMed
    Score: 0.130
  40. Cognitive burden of anticholinergic medications in psychotic disorders. Schizophr Res. 2017 12; 190:129-135.
    View in: PubMed
    Score: 0.125
  41. Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder. Schizophr Bull. 2017 03 01; 43(2):397-406.
    View in: PubMed
    Score: 0.125
  42. Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives. J Psychiatr Res. 2016 Jun; 77:52-8.
    View in: PubMed
    Score: 0.116
  43. Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study. Schizophr Res. 2015 Dec; 169(1-3):326-333.
    View in: PubMed
    Score: 0.113
  44. Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit. Schizophr Res. 2014 Nov; 159(2-3):491-8.
    View in: PubMed
    Score: 0.105
  45. Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study. Schizophr Bull. 2015 Jul; 41(4):940-50.
    View in: PubMed
    Score: 0.105
  46. Emotion recognition deficits in schizophrenia-spectrum disorders and psychotic bipolar disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Schizophr Res. 2014 Sep; 158(1-3):105-12.
    View in: PubMed
    Score: 0.104
  47. Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophr Bull. 2014 Nov; 40(6):1374-84.
    View in: PubMed
    Score: 0.101
  48. Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories. Schizophr Bull. 2014 Sep; 40(5):1011-21.
    View in: PubMed
    Score: 0.098
  49. Neurophysiological evidence of corollary discharge function during vocalization in psychotic patients and their nonpsychotic first-degree relatives. Schizophr Bull. 2013 Nov; 39(6):1272-80.
    View in: PubMed
    Score: 0.093
  50. Genome-wide linkage analysis of 972 bipolar pedigrees using single-nucleotide polymorphisms. Mol Psychiatry. 2012 Jul; 17(8):818-26.
    View in: PubMed
    Score: 0.084
  51. Family-based association of YWHAH in psychotic bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 05; 150B(7):977-83.
    View in: PubMed
    Score: 0.075
  52. Further evidence for an association of G72/G30 with schizophrenia in Chinese. Schizophr Res. 2009 Feb; 107(2-3):324-6.
    View in: PubMed
    Score: 0.069
  53. A family study of rapid-cycling bipolar illness. J Affect Disord. 1988 Jul-Aug; 15(1):87-91.
    View in: PubMed
    Score: 0.068
  54. A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 1988 Apr; 45(4):328-36.
    View in: PubMed
    Score: 0.067
  55. Clinical features of illness in siblings with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1987 Oct; 44(10):891-6.
    View in: PubMed
    Score: 0.065
  56. Birth-cohort changes in manic and depressive disorders in relatives of bipolar and schizoaffective patients. Arch Gen Psychiatry. 1987 Apr; 44(4):314-9.
    View in: PubMed
    Score: 0.063
  57. Validation of criteria for major depression through controlled family study. J Affect Disord. 1986 Sep-Oct; 11(2):125-31.
    View in: PubMed
    Score: 0.060
  58. Genetics of the major psychoses. Res Publ Assoc Res Nerv Ment Dis. 1983; 60:121-44.
    View in: PubMed
    Score: 0.047
  59. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry. 1982 Oct; 39(10):1157-67.
    View in: PubMed
    Score: 0.046
  60. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019 05; 51(5):793-803.
    View in: PubMed
    Score: 0.036
  61. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry. 2013 Nov; 170(11):1275-84.
    View in: PubMed
    Score: 0.025
  62. A high-risk study of bipolar disorder. Childhood clinical phenotypes as precursors of major mood disorders. Arch Gen Psychiatry. 2011 Oct; 68(10):1012-20.
    View in: PubMed
    Score: 0.021
  63. Close linkage of c-Harvey-ras-1 and the insulin gene to affective disorder is ruled out in three North American pedigrees. Nature. 1987 Feb 26-Mar 4; 325(6107):806-8.
    View in: PubMed
    Score: 0.015
  64. Clinical findings in patients with anorexia nervosa and affective illness in their relatives. Am J Psychiatry. 1984 Nov; 141(11):1419-22.
    View in: PubMed
    Score: 0.013
  65. Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees. Biol Psychiatry. 2004 Jul 01; 56(1):18-23.
    View in: PubMed
    Score: 0.013
  66. Information from relatives. Diagnosis of affective disorders. Arch Gen Psychiatry. 1984 Feb; 41(2):173-80.
    View in: PubMed
    Score: 0.013
  67. Segregation and linkage analyses in families of patients with bipolar, unipolar, and schizoaffective mood disorders. Am J Hum Genet. 1983 Mar; 35(2):274-87.
    View in: PubMed
    Score: 0.012
  68. Relationship of HLA to major affective disorder not supported. Psychiatry Res. 1982 Aug; 7(1):29-45.
    View in: PubMed
    Score: 0.011
  69. Follow-up study on a susceptibility locus for schizophrenia on chromosome 6q. Am J Med Genet. 1999 Aug 20; 88(4):337-43.
    View in: PubMed
    Score: 0.009
  70. No abnormality in the gene for the G protein stimulatory alpha subunit in patients with bipolar disorder. Arch Gen Psychiatry. 1997 Jan; 54(1):44-8.
    View in: PubMed
    Score: 0.008
  71. Diagnostic accuracy and confusability analyses: an application to the Diagnostic Interview for Genetic Studies. Psychol Med. 1996 Mar; 26(2):401-10.
    View in: PubMed
    Score: 0.007
  72. Sociocultural and demographic correlates of affective disorders in Jerusalem. J Psychiatr Res. 1975 Apr; 12(1):37-50.
    View in: PubMed
    Score: 0.007
  73. Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. Arch Gen Psychiatry. 1994 Nov; 51(11):912-7.
    View in: PubMed
    Score: 0.007
  74. Plasma MHPG in rapid cyclers and healthy twins. Arch Gen Psychiatry. 1981 Nov; 38(11):1287-90.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.